Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: RaySearch Laboratories AB

Market Cap 7.54B 790M 686M 632M 592M 1.11B 75.68B 1.13B 2.92B 36.48B 2.97B 2.9B 127B P/E Ratio 2026 *
26.4x
P/E Ratio 2027 * 21.2x
Enterprise Value 7.45B 781M 678M 625M 585M 1.09B 74.78B 1.12B 2.89B 36.05B 2.93B 2.87B 125B EV / Sales 2026 *
5.29x
EV / Sales 2027 * 4.54x
Free-Float
85.52%
Yield 2026 *
1.82%
Yield 2027 * 2.35%
1 day-2.59%
1 week-5.16%
Current month-2.82%
1 month+20.77%
3 months+12.32%
6 months-7.82%
Current year-6.40%
1 week 209.8
Extreme 209.8
227.6
1 month 173.6
Extreme 173.6
227.6
Current year 166.8
Extreme 166.8
237.2
1 year 166.8
Extreme 166.8
373.5
3 years 55.6
Extreme 55.6
373.5
5 years 40
Extreme 40
373.5
10 years 40
Extreme 40
373.5
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Director/Board Member 57 01/01/2000
Chairman 81 18/11/2016
Chairman 87 30/09/2022
Date Insider Type Main position Quantity % Market Cap.
12-17Fiscal year

Founder

1,021,577 3.5685%
12-17Fiscal year

Founder

1,021,577 12.0826%
11-14Buy

Director

3,915 0.0137%
Change 5-day change 1-year change 3-year change Capi.($)
-3.00%-5.16%-34.03%+207.94% 796M
-0.63%-8.78%-43.54%-14.47% 26.6B
+0.75%+1.98%-42.57%+158.07% 11.85B
-3.20%+1.89%-8.70%+55.93% 6.35B
+4.35%+7.22% - - 2.54B
-1.61%-13.85%+23.59%-48.08% 1.74B
-0.87%-11.19% - - 1.69B
+0.31%-3.48%-34.34% - 1.26B
-3.29%-6.12%-35.47%-60.11% 835M
+3.80%+7.04%-33.73%-41.17% 760M
Average -0.30%+0.64%-26.10%+36.87% 5.44B
Weighted average by Cap. -0.42%-2.68%-35.92%+37.69%

Financials

2026 *2027 *
Net sales 1.41B 148M 128M 118M 111M 207M 14.14B 211M 546M 6.82B 554M 542M 23.7B 1.6B 168M 146M 134M 126M 235M 16.09B 240M 621M 7.75B 631M 617M 26.96B
Net income 285M 29.87M 25.92M 23.89M 22.39M 41.83M 2.86B 42.7M 110M 1.38B 112M 110M 4.79B 355M 37.2M 32.29M 29.76M 27.88M 52.1M 3.56B 53.19M 137M 1.72B 140M 137M 5.97B
Net Debt -90M -9.43M -8.18M -7.54M -7.07M -13.21M -903M -13.48M -34.84M -435M -35.41M -34.64M -1.51B -265M -27.77M -24.1M -22.21M -20.82M -38.89M -2.66B -39.7M -103M -1.28B -104M -102M -4.46B
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
465
Date Price Change Volume
11/06/26 213.40 kr -3.00% 150,673
10/06/26 220.00 kr +1.29% 151,532
09/06/26 217.20 kr +0.37% 129,851
08/06/26 216.40 kr -1.28% 93,008
05/06/26 219.20 kr -2.58% 123,296
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
220.00SEK
Average target price
330.00SEK
Spread / Average Target
+50.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RAY B Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!